Search results
Found 6793 matches for
Researchers from the University of Oxford and their partners have today reported findings from a Phase IIb trial of a candidate malaria vaccine, R21/Matrix-M, which demonstrated high-level efficacy of 77% over 12-months of follow-up.
Population, Global, and Public Health
Population and global health research generates evidence that reliably answers important questions about human health.